Skip to content
TirzepatideReport

Tirzepatide monograph · Evidence review

EOS Health Tirzepatide Review: Cost, Named Partners & Honest Verdict (2026)

An honest 2026 review of EOS Health tirzepatide — named clinical and pharmacy partners, competitive pricing, and 40-state coverage.

Researched & written by Alan Pierce · last updated

Clinical Pharmacology Writer

On this page

Editorial pick

CoreAge Rx

$149/mo flat

Doctor-reviewed tirzepatide with one flat price and built-in human support.

Advertising disclosure · we may earn a commission at no extra cost to you.

Check availability
vs median
$120/mo below the $269 median
Market
$109–$429/mo across 396 providers
Dispensed
Compounded tirzepatide (503A)

Popular alternative

System Labs

A flat $179/month tirzepatide subscription at every dose, from a company that names three physicians and no pharmacy.

$179/mo flat ($99 first month)

Check System Labs availability

EOS Health has a multi-vertical HIPAA-compliant telehealth platform with a genuine "$99" GLP-1 starting offer and savings up to $750 advertised on its own homepage — figures worth confirming against the specific tirzepatide plan you're quoted. Every fact here comes from the company's own published program.

What EOS Health is

EOS Health is a multi-vertical online telehealth service, spanning weight loss, longevity, men's/women's health, and skincare, with U.S.-licensed clinicians and HIPAA-compliant care. It's unusually transparent for this category: it publicly names its clinical partner (Arora Health & Aesthetics, LLC) and pharmacy partner (F&F Pharmacies dba Jungle Jim's) — both worth independently confirming on the specific weight-loss product page.

§ EOS Health — Named Partners and Coverage

ItemDetail
Clinical partnerArora Health & Aesthetics, LLC
Pharmacy partnerF&F Pharmacies dba Jungle Jim's
State coverage40 states
Verified: multi-vertical HIPAA-compliant platform. Named partners, 40-state coverage, $99 starting offer.

What EOS Health costs

The homepage advertises GLP-1s starting at "as little as $99" with savings up to $750 when joining a plan. The specific weight-loss pricing runs $199/month for semaglutide and $289/month for tirzepatide, plus a $100-off first-prescription code (WELCOME100). Those headline prices are "best rate" figures — confirm whether your quote reflects a quarterly-plan rate or the higher standard monthly rate.

Named clinical and pharmacy partners

EOS Health names both its clinical partner (Arora Health & Aesthetics, LLC — the same partner named by Coivas, another provider reviewed on this site) and its pharmacy partner (F&F Pharmacies dba Jungle Jim's) — a real transparency signal. That pharmacy's own page notes it "cannot dispense sterile compounds," worth confirming directly for injectable GLP-1 fulfillment specifically.

State coverage limits

EOS Health is available in only 40 states, excluding California, Nevada, New Jersey, South Carolina, Texas, Massachusetts, Mississippi, New Hampshire, West Virginia, and Delaware — the pharmacy partner is reportedly unlicensed in those states.

The brand-vs-compounded question

EOS Health dispenses compounded medication only — no brand-name or insurance-covered GLP-1 path. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

EOS Health's real strengths: HIPAA-compliant, US-licensed clinical care, and named clinical and pharmacy partners, competitive pricing with a real first-prescription discount, multiple compounded formula options plus optional 130+ biomarker lab add-ons, and free expedited shipping. The trade-offs: only 40 states covered, headline prices are "best rate" figures that may not match your standard monthly quote, it's compounded-only, and the named pharmacy's own disclaimer about sterile compounds is worth directly confirming for injectable fulfillment. As with any GLP-1 program, verify your state's coverage and clarify whether your quote is the best-rate or standard price; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-11, and better than semaglutide head-to-head2 — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

EOS Health's named clinical and pharmacy partners are a genuine transparency signal, and its optional lab add-ons are a real differentiator, but confirm your state's coverage first — it's 40 states, not 50 — and clarify whether your price quote is the advertised best rate or the higher standard rate. For a similarly transparent, named-partner platform with full 50-state coverage, compare it against Elara Health and Wellness or BiltRx. Its named pharmacy, Jungle Jim's, is also used by Healthicare, another provider reviewed on this site — a common shared-infrastructure pattern, not a duplicate. See our best tirzepatide providers ranking for the full field.

Frequently asked questions

How much does tirzepatide cost through EOS Health?

$289/month, with a $100-off first-prescription code available. The homepage advertises GLP-1s starting "as little as $99" and savings up to $750, so confirm which figure applies to your specific quote.

Does EOS Health name its clinical and pharmacy partners?

Yes — Arora Health & Aesthetics, LLC for clinical care, and F&F Pharmacies dba Jungle Jim's for compounding.

Is EOS Health available in all 50 states?

No — only 40 states, excluding CA, NV, NJ, SC, TX, MA, MS, NH, WV, and DE.

References(2)

  1. Jastreboff AM, Aronne LJ, Ahmad NN, Wharton S, Connery L, Alves B, Kiyosue A, Zhang S, Liu B, Bunck MC, Stefanski A, and the SURMOUNT-1 Investigators (2022). Tirzepatide Once Weekly for the Treatment of Obesity.. New England Journal of Medicine. PMID: 35658024. https://pubmed.ncbi.nlm.nih.gov/35658024/
  2. Aronne LJ, Horn DB, le Roux CW, Ho W, Falcon BL, Bays HE, et al. (2025). Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5).. New England Journal of Medicine. PMID: 40353578. https://pubmed.ncbi.nlm.nih.gov/40353578/

About the author

Alan Pierce

Clinical Pharmacology Writer

About Tirzepatide Report · How we verify prices · This page last updated August 2026

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.